Related Experiment Video
Updated: Jul 5, 2026
07:46
In Vitro Differentiation of Naive CD4+ T Cells into Pathogenic Th17 Cells in Mouse
Published on: October 25, 2024
Statins' immunomodulatory potential against Th17 cell-mediated autoimmune response
Xin Zhang1, Silva Markovic-Plese
1Department of Neurology, University of North Carolina at Chapel Hill, 6109 Neuroscience Research Building, 103 Mason Farm Road, Chapel Hill, NC 27599, USA.
Immunologic Research
|May 20, 2008
Summary
Simvastatin, a statin, modulates immune cells and reduces IL-17, offering potential for treating autoimmune diseases like multiple sclerosis (MS). This study highlights simvastatin
Area of Science:
- Immunology
- Pharmacology
- Neuroscience
Background:
- Statins possess anti-inflammatory properties, suggesting roles beyond cholesterol reduction.
- Chronic inflammatory and autoimmune diseases are increasingly targeted by novel therapeutic strategies.
Purpose of the Study:
- To investigate the immunomodulatory effects of simvastatin on human monocytes and CD4+ cells.
- To explore simvastatin's potential in mitigating autoimmune responses, particularly in the context of multiple sclerosis (MS).
Main Methods:
- Simvastatin treatment of human monocytes and CD4+ T cells.
- Analysis of cytokine production by monocytes.
- Assessment of Interleukin-17 (IL-17) production in CD4+ cells.
Main Results:
- Simvastatin demonstrated an independent immunomodulatory effect on monocytes and CD4+ cells.
- Simvastatin influenced monocyte cytokine production, impacting Th17 cell differentiation.
- Direct inhibition of IL-17 production by simvastatin in CD4+ cells was observed.
Conclusions:
- Simvastatin exhibits direct immunomodulatory effects on key immune cells.
- These effects, including IL-17 inhibition, suggest a therapeutic potential for simvastatin in autoimmune diseases like MS.
- Further research into simvastatin's role in CNS inflammatory diseases is warranted.
Related Concept Videos
01:24T Cell Types and Functions
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
01:29Autoimmune Disorders
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune system...
Concept and Mechanism of Autoimmune Diseases
The immune system...
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
01:20Myasthenia Gravis: Overview and Treatment
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...